Clinical study of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hypertriglyceridemia-induced acute pancreatitis and acute biliary pancreatitis with persistent organ failure

Table 4 Predictive performance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and the acute pancreatitis Scoring System for the occurrence of persistent organ failure in hypertriglyceridemia-induced acute pancreatitis

Parameters	AUC	95%CI		Sensitivity	Specificity	P value
		Lower	Upper
MCTSI	0.718	0.649	0.786	0.650	0.733	< 0.001
JSS	0.703	0.631	0.775	0.663	0.720	< 0.001
BISAP	0.705	0.634	0.775	0.725	0.652	< 0.001
Modified Marshall	0.772	0.708	0.835	0.663	0.795	< 0.001
SOFA	0.827	0.772	0.882	0.713	0.820	< 0.001
PLR	0.622	0.546	0.699	0.413	0.826	0.002
NLR	0.619	0.546	0.693	0.800	0.720	0.003

CI: Confidence interval; AUC: Area under the curve; MCTSI: Modified computed tomography severity index score; JSS: Japanese Severity Score; BISAP: Bedside Index of Severity in Acute Pancreatitis; Modified Marshall: Modified Organ Dysfunction Score; SOFA: Sequential Organ Failure Assessment Score; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio.